Stereotaxis' Continued Leadership in Scientific Outcome Data Prominently Displayed with Multiple Key Presentations at HRS 2011 Read more about Stereotaxis' Continued Leadership in Scientific Outcome Data Prominently Displayed with Multiple Key Presentations at HRS 2011
Stereotaxis Reports First Quarter 2011 Financial Results Read more about Stereotaxis Reports First Quarter 2011 Financial Results
Stereotaxis Introduces New Electrophysiology Platform: Epoch(TM) Read more about Stereotaxis Introduces New Electrophysiology Platform: Epoch(TM)
Stereotaxis to Present at Upcoming Investor Conferences Read more about Stereotaxis to Present at Upcoming Investor Conferences
Stereotaxis to Report First Quarter 2011 Financial Results and Conduct Conference Call on May 2, 2011 Read more about Stereotaxis to Report First Quarter 2011 Financial Results and Conduct Conference Call on May 2, 2011
Stereotaxis Reports 2010 Financial Results, Provides 2011 Financial Outlook Read more about Stereotaxis Reports 2010 Financial Results, Provides 2011 Financial Outlook
Stereotaxis Announces First Worldwide Use of Remote Magnetic Navigation for Renal Ablation to Treat Hypertension Read more about Stereotaxis Announces First Worldwide Use of Remote Magnetic Navigation for Renal Ablation to Treat Hypertension
Stereotaxis Announces Election of Joseph D. Keegan to Board of Directors Read more about Stereotaxis Announces Election of Joseph D. Keegan to Board of Directors
Stereotaxis to Report Fourth Quarter and Full Year 2010 Financial Results and Conduct Conference Call on February 28, 2011 Read more about Stereotaxis to Report Fourth Quarter and Full Year 2010 Financial Results and Conduct Conference Call on February 28, 2011
Stereotaxis Announces CE Mark and First Human Case for Vdrive(TM) Read more about Stereotaxis Announces CE Mark and First Human Case for Vdrive(TM)